Keyphrases
Alcohol
100%
Latent Inhibition
79%
Alcohol Consumption
73%
Glial Cell Line-derived Neurotrophic Factor
69%
Fibroblast Growth factor-2 (FGF-2)
68%
Excessive Drinking
67%
Schizophrenia
55%
Ventral Tegmental Area
52%
Alcohol Use Disorder
50%
Nucleus Accumbens
47%
Alcohol Drinking
44%
Scopolamine
43%
Neuroadaptation
42%
Memory Reconsolidation
42%
Memory Retrieval
37%
Reconsolidation
37%
Antipsychotics
36%
Rodents
32%
Alcohol Intake
29%
Alcohol Abuse
28%
Alcohol Addiction
28%
Ethanol Intake
28%
Alcohol Seeking
28%
Alcohol Reward
27%
Counterconditioning
27%
Activity-dependent Neuroprotective Protein
27%
Mammalian Target of Rapamycin (mTOR)
22%
Ethanol
20%
Amphetamine
20%
Dorsolateral Striatum
19%
Nicotine
19%
Procognitive
19%
Cognitive Enhancer
19%
Brain-derived Neurotrophic Factor
18%
Promoter Expression
18%
Antipsychotic Efficacy
18%
Responsive Genes
18%
Alcohol Use Disorder Treatment
18%
Promoter Methylation
18%
Mesolimbic Dopamine System
18%
Growth Factors
16%
Mesolimbic System
16%
FGF receptor-1
15%
Two-bottle Choice
15%
Positive Symptoms
15%
MK-801
15%
Inhibition Model
15%
Factor Level
15%
Conditioned Place Preference
14%
Relapse Prevention
14%
Neuroscience
Latent Inhibition
81%
Memory Reconsolidation
72%
Glial Cell Line-Derived Neurotrophic Factor
64%
Basic Fibroblast Growth Factor
64%
Ventral Tegmental Area
57%
Antipsychotic
56%
Behavior (Neuroscience)
49%
Nucleus Accumbens
47%
Scopolamine
44%
Messenger RNA
39%
Relapse Prevention
36%
Conditioned Place Preference
34%
Brain-Derived Neurotrophic Factor
31%
Dopaminergic
31%
Enhancer Region
28%
Cognitive Disorders
27%
Amphetamine
22%
Drinking Behavior
21%
Striatum
21%
Neurotrophic Factor
20%
Promoter Region
20%
Glial Cells
19%
Agonist
18%
Methylation
18%
Neuroprotective Agent
18%
Fibroblast Growth Factor Receptor 1
18%
Mammalian Target of Rapamycin Complex 1
17%
Growth Factor
17%
Psychopathology
17%
Cholinergic
14%
Dopaminergic Neuron
13%
Prefrontal Cortex
13%
Reward System
12%
DNA Methylation
12%
Phosphoinositide 3-Kinase
12%
Kinase
12%
Physostigmine
12%
Mental Disorder
11%
Hippocampus
11%
Physical Dependence
11%
Positive Syndrome
9%
Ethanol Metabolism
9%
Acetylcholinesterase Inhibitor
9%
Basolateral Amygdala
9%
Magnetic Resonance Imaging
9%
Lithium Chloride
9%
NADH Dehydrogenase (Ubiquinone)
9%
Neuromodulation
9%
Autoregulation
9%
Histone Deacetylase Inhibitor
9%